TrialNature medicine2025

Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial.

Christian Kurzeder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.